human
cytomegaloviru
cmv
ubiquit
doublestrand
dna
viru
belong
herpesvirida
famili
primari
infect
cmv
usual
asymptomat
intact
immun
system
limit
activ
viral
replic
effect
initi
infect
cmv
rare
caus
selflimit
mononucleosislik
ill
associ
fever
fatigu
myalgia
hepatosplenomegali
howev
cmv
capabl
multipl
immun
evas
mechan
complet
erad
viru
may
achiev
instead
viru
remain
quiescent
within
endotheli
cell
stem
cell
bone
marrow
peripher
blood
monocyt
establish
lifelong
latent
infect
seropreval
cmv
vari
greatli
race
popul
group
older
age
low
socioeconom
statu
lower
educ
level
hivinfect
commonli
associ
greater
cmv
seropreval
immun
system
suppress
latent
cmv
reactiv
replic
rapidli
result
high
level
cmv
viremia
infect
multipl
organ
system
popul
risk
cmv
infect
individu
activ
haematolog
malign
hiv
infect
recipi
hematopoiet
stem
cell
transplant
solid
organ
transplant
individu
signific
immunosuppress
therapi
autoimmun
disord
connect
tissu
diseas
cmv
infect
also
increasingli
recognis
amongst
critic
ill
patient
intens
care
unit
major
immunocompet
prior
ill
advanc
stage
hiv
infect
thelper
cell
function
impair
declin
adapt
immun
respons
crucial
cmv
diseas
control
prior
use
highli
activ
antiretrovir
therapi
haart
preval
cmv
opportunist
infect
oi
acquir
immun
defici
syndrom
aid
high
patient
aid
found
evid
dissemin
cmv
infect
time
autopsi
predomin
manifest
cmv
hivinfect
cmv
retin
affect
patient
account
cmv
relat
complic
organ
affect
cmv
diseas
aid
includ
gastrointestin
tract
peripher
central
nervou
system
liver
kidney
adren
lung
advent
haart
result
substanti
decreas
incid
sever
oi
caus
cmv
aid
cmv
oi
typic
occur
individu
present
aidsdefin
ill
possess
lymphocyt
count
larg
epidemiolog
studi
aidsdefin
opportunist
oi
hivinfect
resid
diagnos
cmv
infect
initi
oi
nil
report
cmv
pneumonia
herein
describ
rare
case
cmv
pneumonia
review
literatur
diagnos
rare
clinic
entiti
hivinfect
patient
heterosexu
man
present
fever
worsen
dyspnoea
period
day
histori
intraven
drug
use
tattoo
previou
blood
transfus
second
present
acut
care
hospit
within
past
month
initi
present
emerg
depart
anoth
hospit
week
ago
symptom
dri
cough
dyspnoea
durat
hiv
serolog
perform
posit
receiv
treatment
bacteri
presumpt
pneumocysti
jirovecii
pjp
pneumonia
subsequ
respiratori
symptom
improv
discharg
oral
trimethoprimsulfamethoxazol
without
corticosteroid
second
present
febril
hypoxem
puls
oximetri
read
ambient
air
initi
chest
radiograph
fig
suggest
bilater
middl
lower
zone
pneumonia
laboratori
investig
confirm
diagnosi
aid
presenc
high
level
cmv
viremia
tabl
start
empir
treatment
bacteri
pjp
pneumonia
iv
piperacillintazobactam
trimethoprimsulfamethoxazol
corticosteroid
despit
fever
respiratori
symptom
fail
improv
differenti
patient
recurr
present
failur
respons
treatment
includ
nosocomi
pneumonia
hivassoci
opportunist
infect
oi
immunolog
reaction
pjp
treatment
comput
tomographi
ct
scan
thorax
reveal
find
consist
infect
atyp
pulmonari
pathogen
fig
c
bronchoscopi
bronchoalveolar
lavag
bal
perform
aid
establis
microbiolog
diagnosi
current
episod
nonresolv
pneumonia
bacteri
cultur
bal
reveal
presenc
escherichia
coli
klebsiella
pneumonia
suscept
piperacillintazobactam
polymeras
chain
reaction
pcr
test
panel
respiratori
virus
opportunist
pathogen
posit
human
coronaviru
rhinoviru
cytomegaloviru
cmv
weakli
posit
pjp
pjp
microscop
examin
perform
bal
neg
suggest
low
pjp
load
consist
histori
recent
pjp
treatment
cytolog
examin
bal
specimen
reveal
viral
cytopath
chang
consist
cmv
infect
fig
cell
count
cellsul
clinic
diagnosi
aid
patient
suscept
host
cmv
reactiv
diseas
clinic
exhibit
new
symptom
sever
respiratori
ill
hypoxemia
antibacteri
pjp
treatment
laboratori
investig
suggest
acut
bacteri
pneumonia
process
ct
thorax
find
patchi
groundglass
attenu
bilater
subcentimetr
centrilobular
nodul
airspac
consolid
consist
pneumon
process
take
account
clinic
radiolog
microbiolog
cytolog
find
diagnosi
cmv
pneumonia
establish
patient
start
anticmv
treatment
intraven
ganciclovir
symptom
fever
hypoxemia
resolv
day
treatment
subsequ
anticmv
treatment
convert
week
cours
oral
valganciclovir
haart
start
week
cmv
treatment
minimis
likelihood
immun
reconstitut
inflammatori
syndrom
despit
decreas
incid
cmv
oi
aid
cmv
remain
signific
pathogen
due
propens
interact
hiv
system
immunomodulatori
effect
evalu
individu
present
aid
high
level
clinic
vigil
cmv
infect
maintain
amongst
patient
hiv
presenc
cmv
associ
increas
risk
develop
neurocognit
cardiovascular
cerebrovascular
diseas
henc
cmv
may
indirectli
lead
greater
overal
mortal
nonaid
relat
ill
coinfect
cmv
hiv
promot
persist
subclin
inflammatori
state
alter
tcell
respons
endotheli
smooth
muscl
cell
stimul
produc
increas
amount
proangiogen
factor
inflammatori
cytokin
lead
upregul
atherosclerosi
vascular
degener
rate
within
bodi
cmv
potenti
pathogen
hiv
activ
hiv
provir
dna
increas
intracellular
transport
hiv
transactiv
protein
effect
cell
function
increas
level
cmv
viremia
hiv
viral
replic
activ
also
increas
increas
cmv
activ
invari
lead
hasten
clinic
progress
aid
increas
aidsrel
mortal
pathogen
cmv
lung
hivinfect
host
also
subject
much
interest
children
hiv
infect
cmv
dnaemia
copiesml
found
impair
lung
function
presenc
cmv
lung
may
precipit
recurr
episod
subclin
pneumon
bronchiol
lead
loss
lung
function
infant
children
posit
cmv
serolog
found
specif
ifni
cell
respons
associ
greater
risk
develop
activ
tuberculosi
bacteria
tuberculosi
pjp
remain
commonest
caus
pulmonari
infect
hivinfect
patient
often
harbour
multipl
concomit
oi
exampl
occam
razor
appli
cmv
rare
plausibl
pathogen
lung
advanc
stage
hivinfect
specif
workup
presenc
cmv
pneumonia
perform
patient
aid
fail
respond
empir
bacteri
pjp
treatment
accur
diagnosi
cmv
pneumonia
advanc
hivinfect
challeng
process
would
mandat
full
constel
consist
clinic
radiolog
microbiolog
cytohistolog
featur
case
illustr
continu
clinic
relev
util
bal
aid
microbiolog
diagnosi
pulmonari
infect
advanc
hiv
infect
bal
result
yield
posit
microbiolog
bacteri
viral
fungal
microorgan
diagnost
yield
bal
set
high
often
lead
treatment
modif
microbiolog
evid
cmv
respiratori
specimen
use
sole
diagnost
test
cmv
pneumonia
set
hivinfect
posit
pcr
assay
cmv
patient
bal
specimen
consid
support
diagnost
cmv
pneumonia
approxim
bal
specimen
patient
hivinfect
may
test
posit
cmv
pcr
techniqu
growth
cultur
medium
detect
cmv
respiratori
specimen
via
techniqu
associ
increas
hypoxemia
mortal
like
repres
asymptomat
viral
shed
airway
epitheli
cell
pulmonari
infect
obtain
cytolog
histolog
evid
cmv
infect
within
pulmonari
cell
tissu
essenti
accur
diagnosi
cmv
pneumonia
cmv
direct
cytopath
effect
infect
cell
viru
replic
intracellularli
cmv
inclus
bodi
appear
within
nucleu
cytoplasm
caus
infect
cell
enlarg
chang
highli
specif
cmv
infect
demonstr
cytolog
histolog
evid
cmv
infect
lung
rare
report
hivinfect
patient
undergo
bronchoscopi
lung
biopsi
consist
low
incid
cmv
pneumonia
pneumon
set
hiv
infect
innat
immun
lung
compris
intact
epitheli
surfac
layer
dendrit
cell
macrophag
nk
cell
rel
preserv
aid
remain
effect
repel
cmv
pulmonari
infect
addit
signific
pneumon
unlik
occur
progress
impair
adapt
immun
system
preclud
damag
inflammatori
respons
cmv
antigen
mainstay
treatment
cmv
infect
involv
immun
reconstitut
haart
haart
caus
rapid
declin
hiv
load
regener
host
immun
effect
suppress
cmv
viral
replic
activ
howev
host
immun
system
restor
paradox
damag
inflammatori
respons
cmv
antigen
ensu
patient
cmv
retin
higher
count
initi
haart
therapi
found
greatest
risk
develop
immun
recoveri
vitriti
uveiti
specif
cmv
therapi
may
role
patient
high
level
cmv
viremia
symptomat
end
organ
diseas
case
patient
cmv
rare
caus
pulmonari
oi
set
hivinfect
cmv
pneumonia
care
evalu
amongst
patient
aid
critic
ill
respond
treatment
diagnos
pulmonari
infect
diagnosi
cmv
pneumonia
made
consist
clinic
radiolog
microbiolog
cytohistopatholog
featur
high
degre
clinic
vigil
rare
clinic
entiti
must
maintain
prompt
treatment
anticmv
therapi
effect
augment
clinic
recoveri
author
manuscript
conflict
interest
fund
declar
regard
product
